According to Centessa Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 319.945.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 4.48 | 36.11% |
2023-12-31 | 3.29 | 277.1% |
2022-12-31 | 0.8723 | -57.64% |
2021-12-31 | 2.06 |